Iron Isomaltoside 1000 (Monofer®) in Non-Dialysis Dependent Chronic Kidney Disease and With Renal-Related Anaemia

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 351 participants.

Also called NCT01102413

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 351 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01102413
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Denmark (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01102413. Randomized; no masking; primary purpose treatment. Start 2010-04 (registry gives no type); primary completion 2014-06 (actual). Results posted on 2015-12-03.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Iron Isomaltoside 1000 (Monofer®) in Non-Dialysis Dependent Chronic Kidney Disease and With Renal-Related Anaemia
Condition
Iron Deficiency Anemia
Intervention (Drug)
Monofer
Intervention (Drug)
Iron Sulphate
Lead sponsor
Pharmacosmos A/S (class: industry)

Record details

Record id
cardio:ct-nct01102413
Content hash
774b277328cc60a176c184946c676fa3de0e8fd7fff92814c1fbad0358f201aa